Bill Search

  • Introduced
    Jan 08, 2021
  • Passed House
    Jan 27, 2021
  • Passed Senate
    Mar 23, 2021
  • Signed into Law
    Apr 01, 2021
HB 1139
North Dakota House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Relating to duration limits for opioid therapy and benzodiazepine; and to provide for application.
Last Action See all actions
executive • Apr 05, 2021: Filed with Secretary Of State 04/01
Latest Bill Text See all bill texts

Official Summary/Bill Text

Comments on HB 1139

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Apr 05, 2021 | executive
    • Filed with Secretary Of State 04/01
  • Apr 01, 2021 | House
    • Signed by Governor 03/31
  • Mar 29, 2021 | House
    • Signed by Speaker
    • Sent to Governor
  • Mar 25, 2021 | Senate
    • Signed by President
  • Mar 24, 2021 | House
    • Returned to House
  • Mar 23, 2021 | Senate
    • Second reading, passed, yeas 38 nays 8
  • Mar 22, 2021 | Senate
    • Reported back, do pass, place on calendar 5 1 0
  • Mar 08, 2021 | Senate
    • Bill Hearing, Senate Industry, Business and Labor, 03/08 2:30 PM, Room Fort Union - relating to duration limits for opioid therapy and benzodiazepine
    • Committee Hearing 02:30
  • Feb 15, 2021 | Senate
    • Introduced, first reading, referred Industry, Business and Labor Committee
  • Jan 28, 2021 | Senate
    • Received from House
  • Jan 27, 2021 | House
    • Second reading, passed, yeas 64 nays 26
  • Jan 21, 2021 | House
    • Reported back, do pass, place on calendar 12 1 1
  • Jan 18, 2021 | House
    • Bill Hearing, House Industry, Business and Labor, 01/18 8:00 AM, Room 327C - Duration limits for opioid therapy & benzodiazepine.
    • Committee Hearing 08:00
  • Jan 08, 2021 | House
    • Introduced, first reading, referred Industry, Business and Labor Committee
Documents